Welcure Drugs & Pharmaceuticals Ltd — Updates, 10-04-2025: Company Update

Welcure Drugs & Pharmaceuticals Ltd. has announced a board meeting regarding the certificate received for the quarter and annual year ended 31 March 2025. This confirms that the physical share certificates have successfully transitioned to electronic form, with all associated securities acknowledged and recorded as dematerialized within 15 days.

This update indicates the company's commitment to enhancing operational efficiency and investor accessibility. The successful transition could positively influence investor sentiment by streamlining share transactions, potentially increasing liquidity in the market. Overall, this move supports a favorable outlook for the company's governance and shareholder engagement.